{"id":"weekly-ferrous-sulfate","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Gastrointestinal upset (nausea, abdominal discomfort)"},{"rate":"5-20","effect":"Constipation"},{"rate":"null","effect":"Dark stools"},{"rate":"5-15","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ferrous sulfate is an iron supplement that delivers ferrous (Fe2+) iron, which is readily absorbed in the gastrointestinal tract. The absorbed iron is incorporated into hemoglobin and myoglobin, restoring oxygen-carrying capacity and correcting iron-deficiency anemia. The weekly formulation likely uses a sustained-release or modified-release mechanism to improve tolerability and compliance.","oneSentence":"Ferrous sulfate provides bioavailable iron to replenish depleted iron stores and restore hemoglobin synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:16:10.892Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron-deficiency anemia"},{"name":"Iron supplementation in pediatric populations"}]},"trialDetails":[{"nctId":"NCT05385042","phase":"NA","title":"Iron and Immune Response to Vaccine (IRONMUM)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2022-06-18","conditions":"Pregnancy Related","enrollment":171},{"nctId":"NCT06875947","phase":"NA","title":"EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fakultas Kedokteran Universitas Padjadjaran","startDate":"2025-05-23","conditions":"Iron Deficiency Anemia of Pregnancy, Pregnancy Complications, Inflammation","enrollment":59},{"nctId":"NCT06624709","phase":"NA","title":"The Benefit in Terms of Improvement in Haemoglobin Level at 6 Months in Premature Babies Receiving Alternate Iron Substitution 4 Times a Week Compared to a Daily Substitution","status":"RECRUITING","sponsor":"Riccardo Pfister","startDate":"2024-11-02","conditions":"Premature Birth","enrollment":160},{"nctId":"NCT03212677","phase":"NA","title":"Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers","status":"COMPLETED","sponsor":"Tufts University","startDate":"2017-05-17","conditions":"Iron","enrollment":226},{"nctId":"NCT06642337","phase":"NA","title":"Nutritional Educational Program On Therapy in Iron Deficiency Anemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hawler Medical University","startDate":"2025-02-01","conditions":"Iron Deficiency Anemia (IDA), Nutrition Disorders, Growth Retardation","enrollment":150},{"nctId":"NCT06921343","phase":"NA","title":"Iron Deficiency in Pediatric Celiac Disease: Diet vs. Iron Supplementation Trial","status":"NOT_YET_RECRUITING","sponsor":"Kaplan Medical Center","startDate":"2025-04","conditions":"Celiac Disease in Children, Iron Deficiency","enrollment":150},{"nctId":"NCT06906835","phase":"NA","title":"Comparing Reticulocyte Hemoglobin and Transferrin Saturation to Guide Iron Treatment in People on Dialysis","status":"RECRUITING","sponsor":"King Chulalongkorn Memorial Hospital","startDate":"2025-01-31","conditions":"Hemodialysis, Anemia in End Stage Renal Disease","enrollment":160},{"nctId":"NCT06849479","phase":"NA","title":"Aerobic Exercises on Persisted Post Burn Anemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2025-01-01","conditions":"Burns","enrollment":40},{"nctId":"NCT04691843","phase":"PHASE3","title":"Iron Supplementation and Neurodevelopmental Outcome in ELGANs","status":"COMPLETED","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2021-02-01","conditions":"Iron-deficiency","enrollment":51},{"nctId":"NCT06318858","phase":"NA","title":"Daily and Weekly Iron Supplementation in Infants","status":"RECRUITING","sponsor":"Mahidol University","startDate":"2023-03-15","conditions":"Anemia, Iron Status, Infants","enrollment":300},{"nctId":"NCT06115421","phase":"PHASE4","title":"Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease Patients","status":"UNKNOWN","sponsor":"Alexandria University","startDate":"2023-05-24","conditions":"Anemia in Dialysis-dependent CKD Patients","enrollment":72},{"nctId":"NCT06176430","phase":"PHASE4","title":"Comparison of Twice Weekly Versus Daily Iron Therapy in Treating Anemia in Children With Cerebral Palsy","status":"UNKNOWN","sponsor":"Shaheed Zulfiqar Ali Bhutto Medical University","startDate":"2024-02-01","conditions":"Cerebral Palsy, Iron Deficiency Anemia","enrollment":160},{"nctId":"NCT04137354","phase":"NA","title":"Iron and Vitamin A in School Children","status":"COMPLETED","sponsor":"University Ghent","startDate":"2020-11-02","conditions":"Anemia, Iron Deficiency, Vitamin A Deficiency, Cognitive Development","enrollment":504},{"nctId":"NCT05708170","phase":"PHASE4","title":"Impact of Intravenous Iron on Musculoskeletal Function in Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Liverpool Hope University","startDate":"2023-01","conditions":"Iron Deficiency Anemia","enrollment":100},{"nctId":"NCT03957057","phase":"PHASE3","title":"Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2020-09-10","conditions":"Postpartum Anemia Nos, Iron-deficiency","enrollment":300},{"nctId":"NCT05152641","phase":"PHASE2","title":"Study to Evaluate Efficacy and Safety of BGE-117 in Moderately to Severely Anemic Older Individuals After Major Hip Surgery","status":"WITHDRAWN","sponsor":"BioAge Labs, Inc.","startDate":"2022-04","conditions":"Acute Posthemorrhagic Anemia","enrollment":""},{"nctId":"NCT05165680","phase":"NA","title":"Effect of Aerobic Exercise and Diet on Anthropometric and Hematological Measurements in Obese Anemic Women","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2021-07-03","conditions":"Obesity, Iron Deficiency Anemia","enrollment":60},{"nctId":"NCT02564796","phase":"PHASE2","title":"Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial","status":"TERMINATED","sponsor":"University of California, San Diego","startDate":"2016-11","conditions":"Cyanotic Congenital Heart Disease, Anemia, Cyanosis","enrollment":4},{"nctId":"NCT00223938","phase":"PHASE4","title":"Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.","status":"TERMINATED","sponsor":"Sanofi","startDate":"2003-12-30","conditions":"Anemia","enrollment":112},{"nctId":"NCT02905981","phase":"PHASE2","title":"Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol","status":"TERMINATED","sponsor":"Rockwell Medical Technologies, Inc.","startDate":"2017-01-17","conditions":"Iron-Refractory Iron-Deficiency Anemia","enrollment":1},{"nctId":"NCT03359447","phase":"PHASE4","title":"Iron Deficiency Anemia, Iron Supplementation and Genomic Stability in Infants","status":"UNKNOWN","sponsor":"Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri","startDate":"2017-08-01","conditions":"Anemia, Iron-deficiency","enrollment":204},{"nctId":"NCT00354484","phase":"PHASE3","title":"Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2006-05","conditions":"Postpartum Anemia","enrollment":291},{"nctId":"NCT00395993","phase":"PHASE3","title":"Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-05","conditions":"Anemia","enrollment":456},{"nctId":"NCT00396292","phase":"PHASE3","title":"Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-02","conditions":"Anemia","enrollment":361},{"nctId":"NCT02541708","phase":"PHASE3","title":"IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania","status":"UNKNOWN","sponsor":"Ifakara Health Institute","startDate":"2015-09","conditions":"Iron-Deficiency Anemia","enrollment":230},{"nctId":"NCT02210949","phase":"PHASE4","title":"Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery","status":"TERMINATED","sponsor":"Catharina Ziekenhuis Eindhoven","startDate":"2014-08","conditions":"Heart; Dysfunction Postoperative, Cardiac Surgery, Anemia, Iron-Deficiency","enrollment":7},{"nctId":"NCT01374373","phase":"PHASE4","title":"Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia","status":"COMPLETED","sponsor":"Bio Sidus SA","startDate":"2011-06","conditions":"Antineoplastic Chemotherapy Induced Anemia","enrollment":30},{"nctId":"NCT01210040","phase":"NA","title":"Long-term Iron Supplements and Malaria Risk in Early Pregnancy: a Randomized Controlled Trial","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2011-04","conditions":"Malaria","enrollment":1959},{"nctId":"NCT00867867","phase":"PHASE1","title":"Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2003-10","conditions":"Healthy Participants, Non-anemic Children, Helicobacter Pylori Infection","enrollment":235},{"nctId":"NCT00223977","phase":"PHASE2, PHASE3","title":"2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2003-12","conditions":"Iron Deficiency Anemia","enrollment":146},{"nctId":"NCT01017614","phase":"PHASE3","title":"Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2009-10","conditions":"Inflammatory Bowel Disease","enrollment":350},{"nctId":"NCT01198574","phase":"PHASE3","title":"Sub-clinical Inflammation and Iron Supplementation","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2010-07","conditions":"Anemia","enrollment":402},{"nctId":"NCT00224055","phase":"PHASE4","title":"Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2003-04","conditions":"Anemia, Iron-Deficiency, Kidney Failure, Chronic","enrollment":89},{"nctId":"NCT00224042","phase":"PHASE4","title":"Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2003-04","conditions":"Anemia, Iron-Deficiency, Kidney Failure, Chronic","enrollment":52},{"nctId":"NCT01092377","phase":"NA","title":"The Effects of Iron and Omega-3 Fatty Acid Supplementation on Cognition and Immune Function in Iron Deficient Children","status":"COMPLETED","sponsor":"North-West University, South Africa","startDate":"2010-02","conditions":"Iron Deficiency, Anemia","enrollment":320},{"nctId":"NCT00998998","phase":"NA","title":"The Anemia Control Program: Early Intervention","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1992-04","conditions":"Iron Deficiency Anemia","enrollment":277},{"nctId":"NCT00992823","phase":"NA","title":"Iron Supplementation to Reduce Preschoolers Anemia: Comparison Between Intermittent and Cyclic Procedure","status":"COMPLETED","sponsor":"Sao Jose do Rio Preto Medical School","startDate":"2006-03","conditions":"Anemia","enrollment":99}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Fer-in-sol"],"phase":"marketed","status":"active","brandName":"Weekly Ferrous Sulfate","genericName":"Weekly Ferrous Sulfate","companyName":"Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri","companyId":"instituto-de-desarrollo-e-investigaciones-pedi-tricas-prof-dr-fernando-e-viteri","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Weekly Ferrous Sulfate is a small molecule supplement used to treat conditions such as anemia, iron deficiency, and iron deficiency anemia. It is available in tablet form and has been studied in clinical trials for its safety and efficacy in treating various iron-related conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}